Yamogenin

CAS No. 512-06-1

Yamogenin( —— )

Catalog No. M20844 CAS No. 512-06-1

Yamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 129 In Stock
10MG 189 In Stock
25MG 317 In Stock
50MG 471 In Stock
100MG 681 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Yamogenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Yamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
  • Description
    Yamogenin is a diastereomer of diosgenin which we have identified as the compound responsible for the anti-hyperlipidemic effect of fenugreek.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    512-06-1
  • Formula Weight
    414.6
  • Molecular Formula
    C27H42O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?Ethanol : 10 mg/mL (24.12 mM)
  • SMILES
    C[C@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C
  • Chemical Name
    Spirost-5-en-3-ol (3beta25S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Quyen L T Khoi N H Suong N N et al. Steroid Alkaloids and Yamogenin from Solanum spirale1[J]. Planta Medica 1987 53(03):292-293.
molnova catalog
related products
  • Sevelamer HCl

    Sevelamer HCl is a phosphate binding drug used to treat hyperphosphatemia via binding to dietary phosphate and prevents its absorption.

  • Tracheloside

    Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).

  • 3,5-Di-O-caffeoylqui...

    3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.